This topic contains a solution. Click here to go to the answer

Author Question: The energy content of preterm and term breast milk is _____ calories per ounce. a. 5 b. 10 c. 20 ... (Read 85 times)

ghost!

  • Hero Member
  • *****
  • Posts: 560
The energy content of preterm and term breast milk is _____ calories per ounce.
 a. 5
 b. 10
  c. 20
  d. 25
  e. 30

Question 2

Which of the following statements is true regarding the role of genetics in obesity?
 
 a. One is destined at birth to become obese.
  b. One inherits the potential to become obese.
  c. Obesity genes come from the mother's side of the family.
  d. Obesity genes come from the father's side of the family.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bbburns21

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

c

Answer to Question 2

b




ghost!

  • Member
  • Posts: 560
Reply 2 on: Aug 20, 2018
:D TYSM


xiazhe

  • Member
  • Posts: 331
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

Did you know?

Eating carrots will improve your eyesight. Carrots are high in vitamin A (retinol), which is essential for good vision. It can also be found in milk, cheese, egg yolks, and liver.

Did you know?

There are more bacteria in your mouth than there are people in the world.

Did you know?

People who have myopia, or nearsightedness, are not able to see objects at a distance but only up close. It occurs when the cornea is either curved too steeply, the eye is too long, or both. This condition is progressive and worsens with time. More than 100 million people in the United States are nearsighted, but only 20% of those are born with the condition. Diet, eye exercise, drug therapy, and corrective lenses can all help manage nearsightedness.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library